NCT07353489

Brief Summary

The goal of this retrospective, single-arm is to evaluate the safety and performance of the easyEndo™ Powered Single Use Powered Endoscopic Staplers and Cartridges in thoracic surgery. The main question it aims to answer is the safety and performance of the staplers

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 20, 2025

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2026

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

January 12, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 20, 2026

Completed
Last Updated

January 20, 2026

Status Verified

January 1, 2026

Enrollment Period

1 month

First QC Date

January 12, 2026

Last Update Submit

January 19, 2026

Conditions

Lung Cancer (NSCLC)

Outcome Measures

Primary Outcomes (1)

  • stapling success rate

    no leakage intra-operation and post-operation

    Perioperative/Periprocedural

Secondary Outcomes (8)

  • Intraoperative blood loss volume

    Perioperative/Periprocedural

  • Blood transfusion requirement

    Perioperative/Periprocedural

  • Conversion to open thoracotomy

    Perioperative/Periprocedural

  • Length of hospital stay

    Perioperative/Periprocedural

  • Postoperative drainage duration

    Perioperative/Periprocedural

  • +3 more secondary outcomes

Study Arms (1)

easyEndoTM Powered Single Use Powered Endoscopic Staplers and Cartridges

EXPERIMENTAL
Device: easyEndoTM Powered Single Use Powered Endoscopic Staplers and Cartridges

Interventions

easyEndoTM Powered Single Use Powered Endoscopic Staplers and CartridgesDEVICE

Using easyEndoTM Powered Single Use Powered Endoscopic Staplers and Cartridges transection, resection, and/or creation of anastomoses in thoracic surgery

easyEndoTM Powered Single Use Powered Endoscopic Staplers and Cartridges

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients who underwent thoracic surgery (including lobectomy, segmentectomy, wedge resection, etc.) using easyEndo™ Powered Single-Use Powered Endoscopic Staplers and Cartridges at our hospital.
  • Surgery date was on or after January 1, 2024.
  • Patients with complete medical records (including demographic data, surgical details, perioperative management, and follow-up information).
  • Patients who completed a 1-year postoperative follow-up, with available and valid follow-up data

You may not qualify if:

  • Patients who used other brands or types of endoscopic staplers instead of easyEndo™ Powered Single-Use Powered Endoscopic Staplers and Cartridges during surgery.
  • Surgery date was before January 1, 2024.
  • Patients with incomplete medical records or missing key information (e.g., unclear surgical procedures, unrecorded stapler use details, lost to follow-up before 1 year).
  • Patients with severe underlying diseases that may affect postoperative outcomes or follow-up, such as end-stage heart, liver, or kidney disease, severe coagulation disorders, or uncontrolled malignant tumors (other than the primary disease requiring thoracic surgery).
  • Patients with allergies to the materials of easyEndo™ staplers or cartridges, or who experienced adverse reactions related to stapler material allergies intraoperatively or postoperatively.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Affiliated Hospital of Jining Medical University

Jining, Shandong, 272000, China

Location

MeSH Terms

Conditions

Lung NeoplasmsCarcinoma, Non-Small-Cell Lung

Condition Hierarchy (Ancestors)

Respiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract DiseasesCarcinoma, BronchogenicBronchial Neoplasms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 12, 2026

First Posted

January 20, 2026

Study Start

November 20, 2025

Primary Completion

January 1, 2026

Study Completion

January 1, 2026

Last Updated

January 20, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

Locations

CN(1)